Quick Answer
Entera Bio Ltd. reported Operating Income of -$11.53 million for fiscal year 2025.
Entera Bio Ltd. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$11.53M | -20.3% |
| 2024 | -$9.59M | -7.8% |
| 2023 | -$8.89M | +31.7% |
| 2022 | -$13.02M | -6.5% |
| 2021 | -$12.22M | -9.4% |
| 2020 | -$11.17M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.26M | -7.8% | -22.0% |
| June 30, 2025 | -$2.67M | -23.2% | -4.1% |
| March 31, 2025 | -$2.56M | -24.3% | +15.2% |
| September 30, 2024 | -$3.02M | -26.6% | -39.5% |
| June 30, 2024 | -$2.17M | +7.1% | -5.0% |
| March 31, 2024 | -$2.06M | +6.8% | +13.6% |
| September 30, 2023 | -$2.39M | +16.7% | -2.4% |
| June 30, 2023 | -$2.33M | +28.3% | -5.3% |
- Entera Bio Ltd. showed a decrease of -20.3% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Entera Bio Ltd.’s operating income has declined by 3.2% (from -$11.17 million to -$11.53 million).
- The most recent figure is from Entera Bio Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: